AR107163A1 - Inhibidores de quinasa - Google Patents

Inhibidores de quinasa

Info

Publication number
AR107163A1
AR107163A1 ARP160103941A ARP160103941A AR107163A1 AR 107163 A1 AR107163 A1 AR 107163A1 AR P160103941 A ARP160103941 A AR P160103941A AR P160103941 A ARP160103941 A AR P160103941A AR 107163 A1 AR107163 A1 AR 107163A1
Authority
AR
Argentina
Prior art keywords
quinase
inhibitors
quinase inhibitors
group
formulas
Prior art date
Application number
ARP160103941A
Other languages
English (en)
Inventor
Hurley Christopher
Stephen Robert Jennings Andrew
Armani Elisabetta
Capaldi Carmelida
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of AR107163A1 publication Critical patent/AR107163A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto caracterizado porque es de fórmula (1), donde R¹ se selecciona entre el grupo que consiste en el grupo de fórmulas (2); y sales farmacéuticamente aceptables del mismo.
ARP160103941A 2015-12-23 2016-12-20 Inhibidores de quinasa AR107163A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15202346 2015-12-23

Publications (1)

Publication Number Publication Date
AR107163A1 true AR107163A1 (es) 2018-03-28

Family

ID=55024003

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103941A AR107163A1 (es) 2015-12-23 2016-12-20 Inhibidores de quinasa

Country Status (4)

Country Link
US (1) US9994565B2 (es)
EP (1) EP3394058B1 (es)
AR (1) AR107163A1 (es)
WO (1) WO2017108736A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071144A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
WO1997002289A1 (en) 1995-07-06 1997-01-23 Zeneca Limited Peptide inhibitors of fibronectine
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
YU25500A (sh) 1999-05-11 2003-08-29 Pfizer Products Inc. Postupak za sintezu analoga nukleozida
GB0028383D0 (en) 2000-11-21 2001-01-03 Novartis Ag Organic compounds
EP1241176A1 (en) 2001-03-16 2002-09-18 Pfizer Products Inc. Purine derivatives for the treatment of ischemia
EP1458682B1 (en) 2001-12-20 2006-08-30 Bayer HealthCare AG 1,4-dihydro-1,4-diphenylpyridine derivatives
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
EP1609789A1 (en) 2004-06-23 2005-12-28 Eli Lilly And Company Ureido-pyrazole derivatives and their use as kinase inhibitors
PT1761520E (pt) 2004-06-23 2008-09-15 Lilly Co Eli Inibidores de quinase
GB0502258D0 (en) 2005-02-03 2005-03-09 Argenta Discovery Ltd Compounds and their use
US7897762B2 (en) 2006-09-14 2011-03-01 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of proliferative diseases
TW200837064A (en) 2006-10-04 2008-09-16 Pharmacopeia Inc 8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression
KR20140103925A (ko) 2011-12-09 2014-08-27 키에시 파르마슈티시 엣스. 피. 에이. 4-히드록시-1,2,3,4-테트라히드로나프탈렌-1-일 우레아 및 호흡기 질환의 치료에서의 이들의 용도
ME02624B (me) 2011-12-09 2017-06-20 Chiesi Farm Spa Inhibitori kinaze
CN105377847A (zh) 2013-06-06 2016-03-02 奇斯药制品公司 激酶抑制剂

Also Published As

Publication number Publication date
EP3394058B1 (en) 2020-10-14
US9994565B2 (en) 2018-06-12
US20180127410A9 (en) 2018-05-10
US20170183343A1 (en) 2017-06-29
WO2017108736A1 (en) 2017-06-29
EP3394058A1 (en) 2018-10-31

Similar Documents

Publication Publication Date Title
CL2018001230A1 (es) Tratamiento de osteoartritis
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
ZA201701299B (en) Glycosidase inhibitors
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
AR101995A1 (es) COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
TW201613872A (en) IRAK4 inhibiting agents
CR20160456A (es) Compuestos de heteroarilo o arilo bibíclicos fusionados
ECSP16067303A (es) Heteroarilos y usos de estos
MA39749A (fr) Dérivés de pipéridine-dione
EA201791684A1 (ru) Селективные ингибиторы bace1
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
AR098274A1 (es) Inhibidor de grelina o-acil transferasa
CL2020001752A1 (es) Derivado de oxi-fluoropiperidina como inhibidor de quinasa.
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
EA201691982A1 (ru) 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов
AR105967A1 (es) Sales de un inhibidor de pim quinasa
EA201691600A1 (ru) Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений
ECSP17029203A (es) Inhibidor de cinasa aurora a
CL2018001067A1 (es) Compuesto piranodipiridínico.
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
AR105821A1 (es) COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T
CO2019005165A2 (es) Compuesto de piridona como inhibidor de c-met
CL2017000662A1 (es) Inhibidores de la histona desmetilasa.

Legal Events

Date Code Title Description
FB Suspension of granting procedure